| Code | Display |
| LP101394-7 |
adjusted for maternal weight |
| LP101907-6 |
corrected for age |
| LP115711-6 |
corrected for background |
| LP147359-6 |
adjusted for body weight |
| LP173482-3 |
1st specimen |
| LP173483-1 |
post cyanocobalamin |
| LP190769-2 |
adjusted for lean body mass+urine creatinine |
| LP20174-6 |
adjusted |
| LP20187-8 |
unadjusted |
| LP20440-1 |
corrected for nucleated erythrocytes |
| LP20441-9 |
hematocrit adjusted |
| LP20595-2 |
corrected for total protein |
| LP20603-4 |
adjusted to pH 7.4 |
| LP20606-7 |
saturation adjusted to 0.5 |
| LP20607-5 |
standard |
| LP20608-3 |
adjusted to patient's actual temperature |
| LP20617-4 |
adjusted for sex hormone binding globulin |
| LP208932-6 |
adjusted for age+sex+race+BMI |
| LP241992-9 |
adjusted for age |
| LP242679-1 |
adjusted for age+sex+race+ethnicity+educational attainment |
| LP29645-6 |
corrected for albumin |
| LP310257-3 |
standardized per IFCC-RMP for CDT |
| LP36655-6 |
adjusted for diabetes+weight |
| LP36656-4 |
adjusted for weight |
| LP36657-2 |
adjusted for diabetes |
| LP418256-6 |
corrected for glycerol |
| LP421238-9 |
corrected for ambient CO |
| LP426374-7 |
at end expiration+W sub-maximal exercise |
| LP426574-2 |
normalized |
| LP65567-7 |
adjusted for multiple gestations |
| LP66337-4 |
corrected for glucose |
| LP71889-7 |
adjusted for hemoglobin |
| LP71890-5 |
adjusted to body conditions |
| LP71891-3 |
uncorrected for compressible gas volume setting |
| LP71892-1 |
corrected for compressible gas volume |
| LP94499-8 |
uncorrected for compressible gas volume |
| LP97015-9 |
adjusted to specific gravity 1.024 |
| LP99753-3 |
corrected for heart rate |
| LP100005-0 |
post 6 mg dexamethasone PO overnight |
| LP100697-4 |
7 AM specimen |
| LP101161-0 |
2.75H post dose lactose PO |
| LP101162-8 |
2.25H post dose lactose PO |
| LP101163-6 |
1.75H post dose lactose PO |
| LP101164-4 |
1.25H post dose lactose PO |
| LP101880-5 |
during expiration |
| LP101881-3 |
during inspiration |
| LP101943-1 |
at end expiration |
| LP111141-0 |
Breath |
| LP111513-0 |
8th specimen post CFst |
| LP111514-8 |
9th specimen post CFst |
| LP111515-5 |
10th specimen post CFst |
| LP115673-8 |
end of expiration |
| LP121112-9 |
W methacholine inhaled |
| LP128681-6 |
afternoon specimen |
| LP129061-0 |
30M post maximum clot amplitude |
| LP129068-5 |
30M after maximum clot amplitude after addition of heparinase |
| LP129071-9 |
60M post maximum clot amplitude |
| LP133229-7 |
beginning of call |
| LP133232-1 |
end of call |
| LP133413-7 |
after addition of normal plasma 2H post incubation separate tubes |
| LP135214-7 |
patient arrival |
| LP135215-4 |
patient destination |
| LP135483-8 |
at delivery |
| LP135595-9 |
90M post exercise |
| LP135596-7 |
110M post exercise |
| LP135597-5 |
130M post exercise |
| LP135600-7 |
15M post exercise |
| LP135804-5 |
WO & W contrast |
| LP136078-5 |
developmental joint assessment |
| LP136176-7 |
20M post excision |
| LP136290-6 |
after maximum clot amplitude |
| LP136303-7 |
at dispatch |
| LP140231-4 |
premenopausal |
| LP140232-2 |
postmenopausal |
| LP140677-8 |
post 25 mg/mL methacholine |
| LP145288-9 |
12H post dose ifosfamide |
| LP145289-7 |
post dose ifosfamide |
| LP145290-5 |
7D post dose ifosfamide |
| LP145541-1 |
20M post dose lactose PO |
| LP145542-9 |
40M post dose lactose PO |
| LP145592-4 |
post dialysis/pre dialysis |
| LP150046-3 |
at peritoneal dialysis adequacy measurement |
| LP156504-5 |
PM trough specimen |
| LP156505-2 |
AM peak specimen |
| LP157148-0 |
pre contrast |
| LP157347-8 |
post dose HCG |
| LP157348-6 |
pre dose HCG |
| LP157517-6 |
W contrast IV+W air contrast PR |
| LP157794-1 |
post ejaculate |
| LP172879-1 |
pre dialysis-post dialysis |
| LP173487-2 |
2nd specimen/Streptococcus pneumoniae 12f Ab |
| LP173488-0 |
post amniocentesis |
| LP173490-6 |
pre amniocentesis |
| LP173492-2 |
2nd specimen/Streptococcus pneumoniae 14 Ab |
| LP173496-3 |
1H post 250 ug cortrosyn IM |
| LP173497-1 |
30M post 250 ug cortrosyn IM |
| LP173498-9 |
pre 250 ug cortrosyn IM |
| LP173502-8 |
post dose cyanocobalamin+intrinsic factor/Cobalamins |
| LP173511-9 |
after addition of protein C activator+Factor V depleted plasma/Coagulation surface induced |
| LP173512-7 |
after addition of protein C activator/Coagulation surface induced |
| LP173514-3 |
pre/post XXX challenge |
| LP173515-0 |
immediately after addition of normal plasma/Coagulation surface induced |
| LP173516-8 |
20M post incubation.37 deg c after addition of normal plasma |
| LP173518-4 |
hemodialysis |
| LP174429-3 |
20M post dose corticotropin |
| LP174563-9 |
post therapeutic diet |
| LP175701-4 |
post question response |
| LP182313-9 |
immediately after 1:1 addition of normal plasma |
| LP183687-5 |
usual |
| LP184287-3 |
pre delivery |
| LP185815-0 |
1.25 mg/ml |
| LP185816-8 |
1.25 ug/ml |
| LP185818-4 |
1.6 mmol/L |
| LP186034-7 |
at discharge |
| LP186079-2 |
2nd tube |
| LP186080-0 |
3rd tube |
| LP186081-8 |
4th tube |
| LP186950-4 |
in microenvironment |
| LP187034-6 |
during respiratory pause |
| LP188666-4 |
negative inspiratory force maneuver |
| LP189724-0 |
1st tube |
| LP189877-6 |
1M post dose indocyanine green |
| LP189878-4 |
15M post dose indocyanine green |
| LP190643-9 |
124H post XXX challenge |
| LP190740-3 |
WO & W contrast IV |
| LP190766-8 |
Dibucaine |
| LP192107-3 |
Indocyanine green |
| LP192129-7 |
dibucaine/Cholinesterase |
| LP199196-9 |
24H post incubation |
| LP199198-5 |
24H post XXX challenge |
| LP199669-5 |
6 umol/L |
| LP200132-1 |
2H dwell specimen |
| LP200133-9 |
4H dwell specimen |
| LP200203-0 |
used for drug calculation |
| LP200240-2 |
post XXX g sugar solution PO |
| LP200254-3 |
pre procedure |
| LP200255-0 |
post procedure |
| LP200319-4 |
after addition of factor X activated |
| LP200464-8 |
1.25H post dose arginine+insulin |
| LP200591-8 |
best corrected |
| LP200592-6 |
uncorrected |
| LP200597-5 |
dark-adapted |
| LP200598-3 |
light-adapted |
| LP200612-2 |
W cycloplegia |
| LP200613-0 |
WO cycloplegia |
| LP201231-0 |
at initial diagnosis |
| LP201232-8 |
at final disease stage |
| LP201627-9 |
W indocyanine green IV |
| LP201628-7 |
W fluorescein IV |
| LP20165-4 |
2nd specimen |
| LP20166-2 |
1st specimen |
| LP20167-0 |
pre 250 ug corticotropin IM |
| LP20168-8 |
30M post 250 ug corticotropin IM |
| LP20169-6 |
1H post 250 ug corticotropin IM |
| LP20171-2 |
10H post 1 mg dexamethasone PO overnight |
| LP20172-0 |
17H post 1 mg dexamethasone PO overnight |
| LP20173-8 |
24H post 1 mg dexamethasone PO overnight |
| LP20175-3 |
peak |
| LP20176-1 |
trough |
| LP20177-9 |
0.0% sodium chloride |
| LP20178-7 |
0.30% sodium chloride |
| LP20179-5 |
0.35% sodium chloride |
| LP20180-3 |
0.40% sodium chloride |
| LP20181-1 |
0.45% sodium chloride |
| LP20182-9 |
0.50% sodium chloride |
| LP20183-7 |
0.55% sodium chloride |
| LP20184-5 |
0.60% sodium chloride |
| LP20185-2 |
0.65% sodium chloride |
| LP20186-0 |
0.85% sodium chloride |
| LP20189-4 |
0.75% sodium chloride |
| LP20190-2 |
2H post peritoneal dialysis |
| LP20191-0 |
4H post peritoneal dialysis |
| LP20192-8 |
20M post dose TRH |
| LP20193-6 |
baseline |
| LP20194-4 |
1st specimen post XXX challenge |
| LP20196-9 |
1H post meal |
| LP20197-7 |
post 10H CFst |
| LP20198-5 |
post 12H CFst |
| LP20199-3 |
1H post 25 g xylose PO |
| LP20200-9 |
1H post dose xylose PO |
| LP20201-7 |
2H post 25 g xylose PO |
| LP20202-5 |
30M post 25 g xylose PO |
| LP20203-3 |
post 6H CFst |
| LP20204-1 |
post ejaculation |
| LP20205-8 |
post coitus |
| LP20206-6 |
15M post 50 g lactose PO |
| LP20207-4 |
7H post 75 g glucose PO |
| LP20208-2 |
3H post 25 g xylose PO |
| LP20209-0 |
4H post 25 g xylose PO |
| LP20210-8 |
5H post 25 g xylose PO |
| LP20213-2 |
2.5H post 75 g glucose PO |
| LP20214-0 |
3.5H post 75 g glucose PO |
| LP20215-7 |
4.5H post 75 g glucose PO |
| LP20216-5 |
45M post 50 g lactose PO |
| LP20217-3 |
45M post dose TRH IV |
| LP20218-1 |
post dialysis |
| LP20219-9 |
pre dialysis |
| LP20220-7 |
15M post 100 g glucose PO |
| LP20221-5 |
45M post 100 g glucose PO |
| LP20222-3 |
post immediate spin |
| LP20223-1 |
9H post 3 g metyraPONE PO overnight |
| LP20224-9 |
pre 3 g metyraPONE PO overnight |
| LP20225-6 |
8H post 30 mg/kg metyraPONE PO |
| LP20226-4 |
post 750 mg metyraPONE q4h X 6 |
| LP20228-0 |
1H post 1 ug/kg CRH IV |
| LP20229-8 |
1H post dose insulin IV |
| LP20230-6 |
1M post 1 ug/kg CRH IV |
| LP20231-4 |
30M post 1 ug/kg CRH IV |
| LP20232-2 |
30M post dose insulin IV |
| LP20233-0 |
45M post 1 ug/kg CRH IV |
| LP20234-8 |
45M post dose insulin IV |
| LP20235-5 |
5M post 1 ug/kg CRH IV |
| LP20236-3 |
pre 1 ug/kg CRH IV |
| LP20237-1 |
pre dose insulin IV |
| LP20238-9 |
post dose PO |
| LP20239-7 |
post 15000 U carotene QDx3 for 3D poly |
| LP20240-5 |
90s post 0.5 ug/kg pentagastrin IV |
| LP20241-3 |
10M post 2.4 mg/kg calcium short IV |
| LP20242-1 |
3H post 15 mg/kg calcium gluconate IV |
| LP20243-9 |
4H post 15 mg/kg calcium gluconate IV |
| LP20244-7 |
5M post 0.5 ug/kg pentagastrin IV |
| LP20245-4 |
5M post 2.4 mg/kg calcium short IV |
| LP20246-2 |
pre 0.5 ug/kg pentagastrin IV |
| LP20247-0 |
pre 2.4 mg/kg calcium short IV |
| LP20248-8 |
post calcium infusion |
| LP20249-6 |
1H post 300 ug cloNIDine PO |
| LP20250-4 |
2H post 300 ug cloNIDine PO |
| LP20251-2 |
3H post 300 ug cloNIDine PO |
| LP20252-0 |
pre 300 ug cloNIDine PO |
| LP20253-8 |
24H post 40 ug corticotropin IM BID 3 day |
| LP20254-6 |
48H post 40 ug corticotropin IM BID 3 day |
| LP20255-3 |
48H post 500 ug dexamethasone PO 2.5 day low dose q6h |
| LP20257-9 |
72H post 40 ug corticotropin IM BID 3 day |
| LP20258-7 |
pre 50 ug corticotropin IM 3 day |
| LP20259-5 |
pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| LP20260-3 |
pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| LP20262-9 |
1H post 0.05-0.15 U insulin/kg IV post 12H CFst |
| LP20263-7 |
1H post 250 ug corticotropin IM rapid |
| LP20264-5 |
1H post 250 ug corticotropin IV rapid |
| LP20266-0 |
24H post 2 mg dexamethasone PO 2.5 day high dose q6h |
| LP20267-8 |
24H post 500 ug corticotropin IM |
| LP20268-6 |
24H post 500 ug dexamethasone PO 2.5 day low dose q6h |
| LP20269-4 |
26H post 500 ug dexamethasone PO 2.5 day low dose q6h |
| LP20270-2 |
26H post 2 mg dexamethasone PO 2.5 day high dose q6h |
| LP20271-0 |
2D post 500 ug corticotropin IM |
| LP20272-8 |
30M post 0.05-0.15 U insulin/kg IV post 12H CFst |
| LP20273-6 |
30M post 250 ug corticotropin IM rapid |
| LP20274-4 |
30M post 250 ug corticotropin IV rapid |
| LP20275-1 |
32H post 40 ug corticotropin IM BID 3 day |
| LP20276-9 |
3D post 500 ug corticotropin IM |
| LP20277-7 |
48H post 2 mg dexamethasone PO 2.5 day high dose q6h |
| LP20279-3 |
50H post 500 ug dexamethasone PO 2.5 day low dose q6h |
| LP20280-1 |
50H post 2 mg dexamethasone PO 2.5 day high dose q6h |
| LP20281-9 |
56H post 40 ug corticotropin IM BID 3 day |
| LP20282-7 |
72H post 2 mg dexamethasone PO 2.5 day high dose q6h |
| LP20283-5 |
72H post 500 ug dexamethasone PO 2.5 day low dose q6h |
| LP20284-3 |
8H post 1 mg dexamethasone PO overnight |
| LP20285-0 |
8H post 2 mg dexamethasone PO 2.5 day high dose q6h |
| LP20286-8 |
8H post 500 ug dexamethasone PO 2.5 day low dose q6h |
| LP20287-6 |
8H post 40 ug corticotropin IM BID 3 day |
| LP20288-4 |
9.5H post 8 mg dexamethasone PO overnight high dose |
| LP20289-2 |
9H post 1 mg dexamethasone PO overnight |
| LP20290-0 |
9H post 8 mg dexamethasone PO overnight high dose |
| LP202916-5 |
overnight dwell |
| LP20291-8 |
pre 12H CFst |
| LP20292-6 |
pre 1 mg dexamethasone PO overnight |
| LP20293-4 |
pre 40 ug corticotropin IM 3 day |
| LP20294-2 |
pre 8 mg dexamethasone PO overnight high dose |
| LP20296-7 |
supine |
| LP20309-8 |
1.5H post 40 g galactose PO |
| LP20310-6 |
1H post 40 g galactose PO |
| LP20311-4 |
2H post 40 g galactose PO |
| LP20312-2 |
30M post 40 g galactose PO |
| LP20313-0 |
post 40 g dose PO |
| LP20314-8 |
10M post 0.2 U/kg secretin |
| LP20315-5 |
15M post 0.2 U/kg secretin |
| LP20316-3 |
20M post 0.2 U/kg secretin |
| LP20317-1 |
25M post 0.2 U/kg secretin |
| LP20318-9 |
30M post 0.2 U/kg secretin |
| LP20319-7 |
5M post 0.2 U/kg secretin |
| LP20320-5 |
pre 0.2 U/kg secretin |
| LP20321-3 |
30M post 100 g glucose PO |
| LP20322-1 |
1.5H post 0.5 g/kg glucose IV |
| LP20323-9 |
1.5H post 100 g glucose PO |
| LP20324-7 |
1.5H post 75 g glucose PO |
| LP20325-4 |
10M post 0.5 g/kg glucose IV |
| LP20326-2 |
1H post 0.5 g/kg glucose IV |
| LP20327-0 |
1H post 100 g glucose PO |
| LP20328-8 |
1H post 50 g glucose PO |
| LP20329-6 |
1H post 50 g lactose PO |
| LP20330-4 |
1H post 75 g glucose PO |
| LP20331-2 |
1M post 0.5 g/kg glucose IV |
| LP20332-0 |
20M post 0.5 g/kg glucose IV |
| LP20333-8 |
2H post 100 g glucose PO |
| LP20334-6 |
2H post 50 g lactose PO |
| LP20335-3 |
2H post 75 g glucose PO |
| LP20336-1 |
2H post meal |
| LP20337-9 |
30M post 0.5 g/kg glucose IV |
| LP20338-7 |
30M post 0.1 U/kg insulin |
| LP20339-5 |
30M post 50 g lactose PO |
| LP20340-3 |
30M post 75 g glucose PO |
| LP20341-1 |
3H post 100 g glucose PO |
| LP20342-9 |
3H post 75 g glucose PO |
| LP20343-7 |
3M post 0.5 g/kg glucose IV |
| LP20344-5 |
40M post 0.5 g/kg glucose IV |
| LP20345-2 |
4H post 100 g glucose PO |
| LP20346-0 |
4H post 75 g glucose PO |
| LP20347-8 |
5H post 100 g glucose PO |
| LP20348-6 |
5H post 75 g glucose PO |
| LP20349-4 |
5M post 0.5 g/kg glucose IV |
| LP20350-2 |
6H post 100 g glucose PO |
| LP20351-0 |
pre 0.5 g/kg glucose IV |
| LP20352-8 |
pre 100 g glucose PO |
| LP20353-6 |
pre 50 g lactose PO |
| LP20354-4 |
pre 75 g glucose PO |
| LP20355-1 |
post CFst |
| LP20356-9 |
1.5H post dose TOLBUTamide IV |
| LP20357-7 |
1H post dose TOLBUTamide IV |
| LP20358-5 |
2.5H post dose TOLBUTamide IV |
| LP20359-3 |
2H post dose TOLBUTamide IV |
| LP20360-1 |
30M post dose TOLBUTamide IV |
| LP20361-9 |
3H post dose TOLBUTamide IV |
| LP203623-6 |
Dwell |
| LP20362-7 |
pre dose TOLBUTamide IV |
| LP20363-5 |
post EDTA therapy |
| LP20365-0 |
105M post 100 g lutropin IV |
| LP20366-8 |
15M post 100 g lutropin IV |
| LP20367-6 |
1H post 100 g lutropin IV |
| LP20368-4 |
1H post dose gonadotropin releasing hormone |
| LP20369-2 |
2H post 100 g lutropin IV |
| LP20370-0 |
2H post dose gonadotropin releasing hormone |
| LP20371-8 |
30M post 100 g lutropin IV |
| LP20372-6 |
30M post dose gonadotropin releasing hormone |
| LP20373-4 |
45M post 100 g lutropin IV |
| LP20374-2 |
75M post 100 g lutropin IV |
| LP20375-9 |
pre dose gonadotropin releasing hormone |
| LP20376-7 |
10M post standing |
| LP20377-5 |
post 12H FFst |
| LP20378-3 |
post 8H FFst |
| LP20379-1 |
1H post dose L-dopa PO |
| LP20380-9 |
1H post dose TRH IV |
| LP20381-7 |
2H post dose L-dopa PO |
| LP20382-5 |
30M post dose TRH IV |
| LP20383-3 |
3H post dose L-dopa PO |
| LP20384-1 |
pre dose L-dopa PO |
| LP20385-8 |
pre dose TRH IV |
| LP20386-6 |
5H post 600 ug furosemide PO |
| LP20387-4 |
pre 600 ug furosemide PO |
| LP20388-2 |
3H post 5000 units |
| LP20389-0 |
6H post 5000 units |
| LP20390-8 |
pre 5000 units |
| LP20391-6 |
1H post 1 g/kg glucose PO |
| LP20392-4 |
2H post 1 g/kg glucose PO |
| LP20393-2 |
3H post 1 g/kg glucose PO |
| LP20394-0 |
52H post 250 ug L-dopa TID 2day PO |
| LP20395-7 |
pre 1 g/kg glucose PO |
| LP20396-5 |
pre 250 ug L-dopa TID 2day PO |
| LP20397-3 |
96H post 5000 U HCG IM |
| LP20398-1 |
pre 5000 U HCG IM |
| LP20400-5 |
3D post 25 TU ID |
| LP20401-3 |
3D post 5 TU ID |
| LP20402-1 |
upright |
| LP20403-9 |
post 50 g glucose PO |
| LP20405-4 |
random |
| LP20406-2 |
trough >12h post dose |
| LP20407-0 |
12H post dose |
| LP20408-8 |
24H post dose |
| LP20409-6 |
>6h post dose |
| LP20410-4 |
>12h post dose |
| LP20411-2 |
>45m post bolus dose |
| LP20412-0 |
1-2W post dose |
| LP20413-8 |
48H post dose |
| LP20414-6 |
72H post dose |
| LP20417-9 |
3D post 50 ug Candida albicans ID |
| LP20418-7 |
3D post 0.1 mL mumps ID |
| LP20419-5 |
3D post 50 ug trichophyton ID |
| LP20420-3 |
immediately after addition of normal plasma |
| LP20422-9 |
20M post venistasis |
| LP20423-7 |
10M post venistasis |
| LP20426-0 |
6H post 75 g glucose PO |
| LP20428-6 |
2.5H post 100 g glucose PO |
| LP20429-4 |
3.5H post 100 g glucose PO |
| LP20430-2 |
4.5H post 100 g glucose PO |
| LP20431-0 |
5.5H post 100 g glucose PO |
| LP20432-8 |
6H post 500 mg bentiromide PO |
| LP20433-6 |
2H post 250 ug corticotropin IM |
| LP20434-4 |
45M post 250 ug corticotropin IM |
| LP20435-1 |
1.5H post 250 ug corticotropin IM |
| LP20436-9 |
evening specimen |
| LP20437-7 |
morning specimen |
| LP20438-5 |
12H post peritoneal dialysis |
| LP20442-7 |
post vasectomy |
| LP20443-5 |
1H post XXX challenge |
| LP20444-3 |
2H post XXX challenge |
| LP20445-0 |
3H post XXX challenge |
| LP20446-8 |
2nd specimen post XXX challenge |
| LP20447-6 |
3rd specimen post XXX challenge |
| LP20448-4 |
4th specimen post XXX challenge |
| LP20449-2 |
5th specimen post XXX challenge |
| LP20450-0 |
6th specimen post XXX challenge |
| LP20451-8 |
7th specimen post XXX challenge |
| LP20452-6 |
8th specimen post XXX challenge |
| LP20453-4 |
4th specimen |
| LP20454-2 |
5th specimen |
| LP20455-9 |
4H post XXX challenge |
| LP20456-7 |
9th specimen post XXX challenge |
| LP20457-5 |
10th specimen post XXX challenge |
| LP20458-3 |
30M post XXX challenge |
| LP20459-1 |
20M post XXX challenge |
| LP20460-9 |
2.5H post XXX challenge |
| LP20461-7 |
post XXX challenge |
| LP20462-5 |
2H specimen |
| LP20463-3 |
4H specimen |
| LP20464-1 |
24H specimen |
| LP20465-8 |
3rd specimen |
| LP20466-6 |
6th specimen |
| LP20467-4 |
7th specimen |
| LP20468-2 |
8th specimen |
| LP20470-8 |
7H post meal |
| LP20471-6 |
11th specimen post XXX challenge |
| LP20472-4 |
12th specimen post XXX challenge |
| LP20473-2 |
13th specimen post XXX challenge |
| LP20474-0 |
14th specimen post XXX challenge |
| LP20475-7 |
15th specimen post XXX challenge |
| LP20477-3 |
15M post XXX challenge |
| LP20478-1 |
6.5H post XXX challenge |
| LP20479-9 |
7H post XXX challenge |
| LP20480-7 |
7.5H post XXX challenge |
| LP20481-5 |
8H post XXX challenge |
| LP20482-3 |
9H post XXX challenge |
| LP20483-1 |
10H post XXX challenge |
| LP20484-9 |
12H post XXX challenge |
| LP20485-6 |
15M post dose lactose PO |
| LP20486-4 |
6th specimen post dose lactose |
| LP20487-2 |
3.5H post dose lactose PO |
| LP20488-0 |
10M pre XXX challenge |
| LP20489-8 |
2M post XXX challenge |
| LP20490-6 |
8M post XXX challenge |
| LP20491-4 |
10M post XXX challenge |
| LP20492-2 |
4M post XXX challenge |
| LP20493-0 |
40M post XXX challenge |
| LP20494-8 |
50M post XXX challenge |
| LP20495-5 |
70M post XXX challenge |
| LP20496-3 |
15M pre XXX challenge |
| LP20498-9 |
pre XXX challenge |
| LP20499-7 |
45M post XXX challenge |
| LP20500-2 |
3.5H post XXX challenge |
| LP20501-0 |
4.5H post XXX challenge |
| LP20502-8 |
5.5H post XXX challenge |
| LP20503-6 |
11H post XXX challenge |
| LP20505-1 |
19M post XXX challenge |
| LP20506-9 |
22M post XXX challenge |
| LP20507-7 |
1.5H post XXX challenge |
| LP20509-3 |
70M specimen |
| LP20510-1 |
5H post XXX challenge |
| LP20511-9 |
6H post XXX challenge |
| LP20517-6 |
15M post 250 ug corticotropin |
| LP20518-4 |
1H post 250 ug corticotropin |
| LP20519-2 |
30M post 250 ug corticotropin |
| LP20520-0 |
3H post 50 g lactose PO |
| LP20521-8 |
4H post 50 g lactose PO |
| LP20523-4 |
1H post 25 mg captopril PO |
| LP20524-2 |
2H post 25 mg captopril PO |
| LP20525-9 |
10M post 1 mg glucagon IV |
| LP20526-7 |
15M post 1 mg glucagon IV |
| LP20527-5 |
5M post 1 mg glucagon IV |
| LP20529-1 |
2.5H post 50 g lactose PO |
| LP20530-9 |
5H post 50 g lactose PO |
| LP20531-7 |
1.5H post dose TRH IV |
| LP20532-5 |
15M post dose TRH IV |
| LP20533-3 |
2H post dose TRH IV |
| LP20534-1 |
5.5H post 75 g glucose PO |
| LP20537-4 |
2M post 0.2 U/kg secretin |
| LP20538-2 |
1.5H post 50 g lactose PO |
| LP20548-1 |
immediately after 1:4 addition of normal plasma |
| LP20555-6 |
post dose |
| LP20556-4 |
1.5M post XXX challenge |
| LP20557-2 |
5M post XXX challenge |
| LP20558-0 |
1M post XXX challenge |
| LP20560-6 |
80M post XXX challenge |
| LP20561-4 |
105M post XXX challenge |
| LP20562-2 |
25M post XXX challenge |
| LP20563-0 |
post meal |
| LP20571-3 |
post dose glucose |
| LP20573-9 |
75M post XXX challenge |
| LP20574-7 |
standing |
| LP20575-4 |
3H post dose |
| LP20576-2 |
6H post dose |
| LP20577-0 |
52H post XXX challenge |
| LP20578-8 |
30M post collection |
| LP20587-9 |
4D post XXX challenge |
| LP20588-7 |
post dose TRH |
| LP20589-5 |
post 8H CFst |
| LP20597-8 |
post partum |
| LP20599-4 |
pre partum |
| LP20601-8 |
6H post 50 g lactose PO |
| LP20602-6 |
12H post 50 g lactose PO |
| LP20609-1 |
2H post dose glucose |
| LP20610-9 |
3H post dose glucose |
| LP20611-7 |
1H post dose glucose |
| LP20612-5 |
30M post dose glucose |
| LP20614-1 |
post 50 g glucose |
| LP20615-8 |
1H post dose corticotropin |
| LP20619-0 |
11 PM specimen |
| LP20620-8 |
1H post ejaculation |
| LP20621-6 |
2H post ejaculation |
| LP20622-4 |
3H post ejaculation |
| LP20624-0 |
40M post 0.2 U/kg secretin |
| LP20625-7 |
45M post 0.2 U/kg secretin |
| LP20626-5 |
2.5H post 0.2 U/kg secretin |
| LP20627-3 |
3H post 0.2 U/kg secretin |
| LP20628-1 |
3.5H post 0.2 U/kg secretin |
| LP20629-9 |
4H post 0.2 U/kg secretin |
| LP20630-7 |
50M post 0.2 U/kg secretin |
| LP20631-5 |
7M post 0.2 U/kg secretin |
| LP20632-3 |
1H post 0.2 U/kg secretin |
| LP20633-1 |
1.5H post 0.2 U/kg secretin |
| LP20634-9 |
2H post 0.2 U/kg secretin |
| LP20635-6 |
1M post 0.5 ug/kg pentagastrin IV |
| LP20636-4 |
3M post 0.5 ug/kg pentagastrin IV |
| LP20637-2 |
10M post 0.5 ug/kg pentagastrin IV |
| LP20638-0 |
2M post 0.5 ug/kg pentagastrin IV |
| LP20639-8 |
15M post dose gonadotropin releasing hormone |
| LP20640-6 |
45M post dose gonadotropin releasing hormone |
| LP20643-0 |
4H post ejaculation |
| LP20644-8 |
1H post 5 g xylose PO |
| LP20645-5 |
2H post 5 g xylose PO |
| LP20646-3 |
2H post dose xylose PO |
| LP20647-1 |
post 25 g xylose PO |
| LP20648-9 |
post 5 g xylose PO |
| LP20649-7 |
post dose xylose PO |
| LP20650-5 |
2D post 0.1 mL brucellin ID |
| LP20651-3 |
3D post 0.1 mL brucellin ID |
| LP20652-1 |
1D post 0.1 mL mallein ID |
| LP20653-9 |
2D post 0.1 mL mallein ID |
| LP20654-7 |
1D post dose ID |
| LP20655-4 |
2D post dose ID |
| LP20656-2 |
3D post dose ID |
| LP20657-0 |
3D post 0.1 mL leishmanin ID |
| LP20658-8 |
3D post 0.1 mL avian tuberculin ID |
| LP20659-6 |
3D post 0.1 mL johnin ID |
| LP20660-4 |
post 0.1 mL tricin ID |
| LP20661-2 |
2D post dose mammalian tuberculin ID |
| LP20662-0 |
3D post dose avian tuberculin ID |
| LP20663-8 |
3D post dose mammalian tuberculin ID |
| LP207806-3 |
preoperative |
| LP207893-1 |
post preoperative therapy |
| LP207954-1 |
postoperative |
| LP20815-4 |
5.5H post dose glucose |
| LP20816-2 |
15M post dose glucose |
| LP20819-6 |
1H post 100 ug luteinizing releasing hormone IV |
| LP20820-4 |
30M post 100 ug luteinizing releasing hormone IV |
| LP20821-2 |
1.5H post 100 ug luteinizing releasing hormone IV |
| LP20822-0 |
2H post 100 ug luteinizing releasing hormone IV |
| LP20824-6 |
pre 50 g glucose PO |
| LP20825-3 |
5H post 500 mg calcium PO |
| LP20828-7 |
10M post 200 ug TRH IV |
| LP20829-5 |
1H post 200 ug TRH IV |
| LP20830-3 |
20M post 200 ug TRH IV |
| LP20831-1 |
2H post 200 ug TRH IV |
| LP20832-9 |
30M post 200 ug TRH IV |
| LP20833-7 |
40M post 200 ug TRH IV |
| LP20834-5 |
50M post 200 ug TRH IV |
| LP20849-3 |
1.5H post dose xylose PO |
| LP208591-0 |
post mitogen stimulation |
| LP20861-8 |
1st specimen post exercise |
| LP20862-6 |
2nd specimen post exercise |
| LP20863-4 |
3rd specimen post exercise |
| LP20864-2 |
4th specimen post exercise |
| LP20865-9 |
5th specimen post exercise |
| LP20866-7 |
6th specimen post exercise |
| LP20867-5 |
pre exercise |
| LP20868-3 |
pre 500 mg calcium PO |
| LP20870-9 |
pre dose TRH IN |
| LP20871-7 |
30M post dose TRH IN |
| LP20872-5 |
1D post XXX challenge |
| LP20873-3 |
2D post XXX challenge |
| LP20890-7 |
post pyridoxine PO |
| LP20891-5 |
post 250 mg pyridoxine PO |
| LP20892-3 |
pre 250 mg pyridoxine PO |
| LP209057-1 |
W single state of exercise |
| LP209060-5 |
W multiple states of exercise |
| LP20921-0 |
24H post dose corticotropin |
| LP20922-8 |
8H post dose corticotropin |
| LP20923-6 |
30M post dose corticotropin |
| LP20925-1 |
48H post dose corticotropin |
| LP20926-9 |
72H post dose corticotropin |
| LP20928-5 |
32H post dose corticotropin |
| LP20930-1 |
56H post dose corticotropin |
| LP20931-9 |
4H post dose glucose |
| LP20932-7 |
5H post dose glucose |
| LP20933-5 |
6H post dose glucose |
| LP20934-3 |
1.5H post dose glucose |
| LP20935-0 |
2.5H post dose glucose |
| LP20936-8 |
3.5H post dose glucose |
| LP20937-6 |
4.5H post dose glucose |
| LP20938-4 |
45M post dose glucose |
| LP21153-9 |
4H post dose lactose PO |
| LP21154-7 |
5H post dose lactose PO |
| LP21174-5 |
22nd specimen post XXX challenge |
| LP21175-2 |
18th specimen post XXX challenge |
| LP21176-0 |
24H post ejaculation |
| LP21177-8 |
12H post ejaculation |
| LP21180-2 |
16th specimen post XXX challenge |
| LP21181-0 |
17th specimen post XXX challenge |
| LP21182-8 |
19th specimen post XXX challenge |
| LP21183-6 |
20th specimen post XXX challenge |
| LP21184-4 |
21st specimen post XXX challenge |
| LP21185-1 |
23rd specimen post XXX challenge |
| LP21187-7 |
24th specimen post XXX challenge |
| LP21188-5 |
25th specimen post XXX challenge |
| LP212272-1 |
W contrast retrograde |
| LP213623-4 |
Mitogen |
| LP213625-9 |
18F-NaF |
| LP213626-7 |
Florbetapir |
| LP213627-5 |
Ra-223 |
| LP221198-7 |
W standing |
| LP230193-7 |
at rest |
| LP231610-9 |
pre symptom onset |
| LP231624-0 |
pre 18Yo |
| LP231627-3 |
8 weeks pre symptom onset or diagnosis |
| LP231800-6 |
W 18F-FDG IV |
| LP231997-0 |
post dose follitropin |
| LP231998-8 |
post dose gonadotropin releasing hormone |
| LP232000-2 |
post dose lutropin |
| LP232046-5 |
eyes open+on solid surface |
| LP232049-9 |
eyes closed+on solid surface |
| LP232052-3 |
eyes open+on foam surface |
| LP232055-6 |
eyes closed+on foam surface |
| LP232058-0 |
eyes open+tandem stance+on solid surface |
| LP234189-1 |
18F-FDG |
| LP242680-9 |
2M post trial start |
| LP242694-0 |
Follitropin |
| LP247778-6 |
at onset of illness |
| LP247779-4 |
at cessation of pregnancy |
| LP248244-8 |
at admission |
| LP248531-8 |
week 1 |
| LP248532-6 |
week 2 |
| LP249020-1 |
60M after maximum clot amplitude after addition of heparinase |
| LP249275-1 |
750 ug/mL |
| LP253535-1 |
at intake |
| LP253537-7 |
at exit |
| LP253561-7 |
unladen |
| LP262702-6 |
1st trimester |
| LP262703-4 |
2nd trimester |
| LP264291-8 |
W exercise |
| LP265578-7 |
50M post dose fructose PO |
| LP265579-5 |
40M post dose fructose PO |
| LP265580-3 |
20M post dose fructose PO |
| LP265581-1 |
10M post dose fructose PO |
| LP265582-9 |
10M post dose lactose PO |
| LP265585-2 |
50M post dose lactose PO |
| LP266032-4 |
during pregnancy |
| LP266061-3 |
W Chemotherapy |
| LP266097-7 |
during apnea |
| LP266100-9 |
W pain |
| LP266103-3 |
lying in L-lateral position |
| LP266328-6 |
during anesthesia |
| LP266544-8 |
500 Hz |
| LP266545-5 |
1000 Hz |
| LP266546-3 |
2000 Hz |
| LP266547-1 |
3000 Hz |
| LP266548-9 |
4000 Hz |
| LP266549-7 |
6000 Hz |
| LP266550-5 |
8000 Hz |
| LP266628-9 |
W embolic agent IA |
| LP266708-9 |
W intraarterial hepatic injection |
| LP267360-8 |
pre enrollment in ADAPTABLE study |
| LP267361-6 |
post enrollment in ADAPTABLE study |
| LP267363-2 |
during hospitalization |
| LP269268-1 |
6H post dose levothyroxine |
| LP269269-9 |
4H post dose levothyroxine |
| LP269270-7 |
3H post dose levothyroxine |
| LP269271-5 |
2H post dose levothyroxine |
| LP269272-3 |
1H post dose levothyroxine |
| LP270304-1 |
Levothyroxine |
| LP270822-2 |
250 Hz |
| LP270823-0 |
750 Hz |
| LP270824-8 |
1500 Hz |
| LP270826-3 |
5000 Hz |
| LP281858-3 |
W contrast IV && Multisection |
| LP281862-5 |
W flexion + W extension) |
| LP281867-4 |
W standing) |
| LP281869-0 |
W stress & W radionuclide IV |
| LP281871-6 |
WO contrast && Multisection |
| LP29303-2 |
peak post extended interval dosing |
| LP29304-0 |
trough post extended interval dosing |
| LP29305-7 |
random post extended interval dosing |
| LP29307-3 |
1H post incubation after addition of normal plasma |
| LP29308-1 |
1H post incubation |
| LP29319-8 |
2D post 0.1 mL coccidioidin ID |
| LP29322-2 |
4 PM specimen |
| LP29328-9 |
105M post 100 ug luteinizing releasing hormone IV |
| LP29329-7 |
15M post 100 ug luteinizing releasing hormone IV |
| LP29330-5 |
45M post 100 ug luteinizing releasing hormone IV |
| LP29332-1 |
75M post 100 ug luteinizing releasing hormone IV |
| LP29338-8 |
1M pre XXX challenge |
| LP29339-6 |
30M pre XXX challenge |
| LP29341-2 |
1.5H post dose insulin IV |
| LP29342-0 |
1.6H post dose glucose |
| LP29343-8 |
10 AM specimen |
| LP29344-6 |
11 AM specimen |
| LP29345-3 |
1H post 1.2 g/kg lactose PO |
| LP29346-1 |
2 PM specimen |
| LP29347-9 |
2.3H post dose glucose |
| LP29348-7 |
2.6H post dose glucose |
| LP29349-5 |
20M post dose glucose |
| LP29350-3 |
2H post 1.2 g/kg lactose PO |
| LP29351-1 |
3H post 1.2 g/kg lactose PO |
| LP29353-7 |
3.3H post dose glucose |
| LP29354-5 |
3.6H post dose glucose |
| LP29355-2 |
40M post dose glucose |
| LP29360-2 |
6H post dose methionine |
| LP29361-0 |
1.3H post XXX challenge |
| LP29362-8 |
1.6H post XXX challenge |
| LP29363-6 |
2.3H post XXX challenge |
| LP29364-4 |
2.6H post XXX challenge |
| LP29365-1 |
3.3H post XXX challenge |
| LP29366-9 |
3.6H post XXX challenge |
| LP29370-1 |
post void |
| LP29376-8 |
1H post dose U/kg insulin IV |
| LP29377-6 |
30M post dose U/kg insulin IV |
| LP29378-4 |
1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst |
| LP29380-0 |
1.5H post 100 g lutropin IV |
| LP29381-8 |
1.5H post dose gonadotropin releasing hormone |
| LP29382-6 |
3 PM specimen |
| LP29383-4 |
5 PM specimen |
| LP29451-9 |
6H post ejaculation |
| LP29454-3 |
0.60% sodium chloride 24H 37 deg C incubation |
| LP29455-0 |
0.65% sodium chloride 24H 37 deg C incubation |
| LP29456-8 |
0.75% sodium chloride 24H 37 deg C incubation |
| LP29554-0 |
2.5H post dose xylose PO |
| LP29556-5 |
post dose urea |
| LP29557-3 |
2D post 0.1 mL Candida albicans ID |
| LP29558-1 |
2D post 0.1 mL histoplasmin ID |
| LP29559-9 |
2D post 0.1 mL mumps ID |
| LP29560-7 |
2D post 0.1ml trichophyton ID |
| LP29561-5 |
1.3H post dose glucose |
| LP29584-7 |
post dose cyanocobalamin |
| LP29586-2 |
post dose cyanocobalamin+intrinsic factor |
| LP29587-0 |
0.0% sodium chloride 24H 37 deg C incubation |
| LP29588-8 |
0.85% sodium chloride 24H 37 deg C incubation |
| LP29589-6 |
0.55% sodium chloride 24H 37 deg C incubation |
| LP29590-4 |
0.50% sodium chloride 24H 37 deg C incubation |
| LP29591-2 |
0.45% sodium chloride 24H 37 deg C incubation |
| LP29592-0 |
0.40% sodium chloride 24H 37 deg C incubation |
| LP29593-8 |
0.35% sodium chloride 24H 37 deg C incubation |
| LP29594-6 |
0.30% sodium chloride 24H 37 deg C incubation |
| LP29596-1 |
20M post incubation after addition of normal plasma |
| LP29600-1 |
lying |
| LP30662-8 |
1D post 50 ug Candida albicans ID |
| LP30663-6 |
2D post 50 ug Candida albicans ID |
| LP30664-4 |
1D post 0.1 mL mumps ID |
| LP30665-1 |
2D post 50 ug trichophyton ID |
| LP30666-9 |
1D post 50 ug trichophyton ID |
| LP30667-7 |
1D post dose mammalian tuberculin ID |
| LP30766-7 |
45M post dose lactose PO |
| LP30784-0 |
fresh |
| LP30785-7 |
Incubated |
| LP30795-6 |
30M post 1.2 g/kg lactose PO |
| LP30852-5 |
2H post dose lactose PO |
| LP30853-3 |
2.5H post dose lactose PO |
| LP30854-1 |
3H post dose lactose PO |
| LP30856-6 |
pre dose lactose PO |
| LP30857-4 |
30M post dose lactose PO |
| LP30858-2 |
1H post dose lactose PO |
| LP30859-0 |
1.5H post dose lactose PO |
| LP30871-5 |
High dose |
| LP30872-3 |
Low dose |
| LP30879-8 |
1500 ug/mL |
| LP30880-6 |
1200 ug/mL |
| LP30881-4 |
900 ug/mL |
| LP30882-2 |
600 ug/mL |
| LP30883-0 |
300 ug/mL |
| LP30921-8 |
immediately after addition of protamine sulfate |
| LP309958-9 |
5M pre 1 ug/kg CRH IV |
| LP309959-7 |
1M pre 1 ug/kg CRH IV |
| LP309960-5 |
2M post 1 ug/kg CRH IV |
| LP309961-3 |
10M post 1 ug/kg CRH IV |
| LP310239-1 |
post birth |
| LP31506-6 |
pre dose radioactive cyanocobalamin |
| LP31581-9 |
2H post dose |
| LP31582-7 |
6H post dose methionine - post CFst |
| LP31583-5 |
30M post dose TRH |
| LP31584-3 |
1H post dose TRH |
| LP31585-0 |
1.5H post dose TRH |
| LP31586-8 |
2H post dose TRH |
| LP31587-6 |
pre dose TRH |
| LP31593-4 |
2H post incubation after addition of normal plasma |
| LP31597-5 |
15M post incubation |
| LP31599-1 |
1H post incubation after 1:4 addition of normal plasma |
| LP31600-7 |
2H post incubation after 1:4 addition of normal plasma |
| LP31604-9 |
30M post incubation |
| LP31605-6 |
2H post incubation |
| LP31612-2 |
1.5H post 200 ug TRH IV |
| LP31751-8 |
15M post 250 ug corticotropin IM |
| LP31752-6 |
10M post dose glucose |
| LP31761-7 |
pre or post dose TRH |
| LP31762-5 |
pre or post XXX challenge |
| LP31763-3 |
pre or post dose arginine |
| LP31764-1 |
pre or post dose cloNIDine |
| LP31765-8 |
pre or post dose glucagon |
| LP31766-6 |
pre or post dose glucose |
| LP31767-4 |
pre or post dose insulin |
| LP31768-2 |
pre or post dose corticotropin |
| LP31784-9 |
30M post incubation after addition of normal plasma |
| LP31942-3 |
immediately after 1:2 addition of normal plasma |
| LP32460-5 |
1st specimen/2nd specimen |
| LP32462-1 |
2nd specimen/1st specimen |
| LP32529-7 |
Corticotropin |
| LP32530-5 |
Dexamethasone |
| LP32532-1 |
Xylose |
| LP32533-9 |
Lactose |
| LP32534-7 |
Glucose |
| LP32542-0 |
insulin |
| LP32547-9 |
Calcium |
| LP32548-7 |
cloNIDine |
| LP32549-5 |
Cyanocobalamin |
| LP32557-8 |
Gonadotropin releasing hormone |
| LP32562-8 |
Glucagon |
| LP32568-5 |
Pyridoxine |
| LP32571-9 |
Methionine |
| LP32575-0 |
Arginine |
| LP32576-8 |
Bentiromide |
| LP32624-6 |
Candida albicans |
| LP32625-3 |
Tuberculin |
| LP32628-7 |
Trichophyton |
| LP32647-7 |
Urea |
| LP32689-9 |
Captopril |
| LP32690-7 |
Carotene |
| LP32693-1 |
Furosemide |
| LP32694-9 |
Galactose |
| LP32697-2 |
Luteinizing releasing hormone |
| LP32698-0 |
Lutropin |
| LP32699-8 |
metyraPONE |
| LP32704-6 |
Secretin |
| LP32705-3 |
TOLBUTamide |
| LP32711-1 |
immediately after addition of factor V depleted plasma |
| LP32712-9 |
immediately after addition of factor IX depleted plasma |
| LP32713-7 |
immediately after addition of factor XIII depleted plasma |
| LP32714-5 |
immediately after addition of factor X depleted plasma |
| LP32715-2 |
immediately after addition of factor II depleted plasma |
| LP32716-0 |
immediately after addition of factor XI depleted plasma |
| LP32717-8 |
immediately after addition of factor XII depleted plasma |
| LP33014-9 |
0.10% sodium chloride 24H 37 deg C incubation |
| LP33015-6 |
0.10% sodium chloride |
| LP33016-4 |
0.20% sodium chloride 24H 37 deg C incubation |
| LP33017-2 |
0.20% sodium chloride |
| LP33161-8 |
5th specimen post dose sincalide |
| LP33162-6 |
4th specimen post dose sincalide |
| LP33163-4 |
3rd specimen post dose sincalide |
| LP33164-2 |
2nd specimen post dose sincalide |
| LP33165-9 |
1st specimen post dose sincalide |
| LP33221-0 |
post reanastomosis |
| LP33254-1 |
6H post XXX bentiromide PO |
| LP33263-2 |
10M post excision |
| LP33383-8 |
W contrast |
| LP33384-6 |
W contrast IA |
| LP33385-3 |
W contrast IV |
| LP33392-9 |
WO contrast |
| LP33407-5 |
W contrast IS |
| LP33408-3 |
W contrast IT |
| LP33535-3 |
W anesthesia |
| LP33538-7 |
W contrast PO |
| LP33557-7 |
W gastrografin PO |
| LP33650-0 |
W radionuclide IV |
| LP33651-8 |
W contrast PR |
| LP33654-2 |
W contrast PO during swallowing |
| LP33955-3 |
W Tc-99m IV |
| LP33957-9 |
W Tc-99m |
| LP33958-7 |
W Tc-99m MAA IV |
| LP33961-1 |
W Tc-99m pertechnetate IV |
| LP33992-6 |
W manual stress |
| LP34036-1 |
during surgery |
| LP34055-1 |
W contrast percutaneous |
| LP34082-5 |
W weight |
| LP34196-3 |
W expiration |
| LP34197-1 |
W inspiration |
| LP34201-1 |
W cholecystokinin |
| LP34214-4 |
W contrast intra bladder |
| LP34228-4 |
Sincalide |
| LP34255-7 |
W air |
| LP34258-1 |
W contrast intra duct |
| LP34265-6 |
W contrast antegrade |
| LP34306-8 |
5M post excision |
| LP34578-2 |
pre dose |
| LP34579-0 |
30M post dose |
| LP34580-8 |
1H post dose |
| LP34581-6 |
1.5H post dose |
| LP34582-4 |
2.5H post dose |
| LP34689-7 |
post washing |
| LP34690-5 |
pre washing |
| LP34729-1 |
pre or post dose dexamethasone |
| LP34756-4 |
W flexion |
| LP34757-2 |
W extension |
| LP34761-4 |
W R-bending |
| LP34762-2 |
W L-bending |
| LP34898-4 |
W flexion + W extension |
| LP34945-3 |
W R-bending + W L-bending |
| LP34953-7 |
pre {event} |
| LP34954-5 |
post {event} |
| LP34960-2 |
at time of {event} |
| LP35145-9 |
W air contrast PO |
| LP35298-6 |
48H post contrast PO |
| LP35299-4 |
1st specimen post dose lactose |
| LP35300-0 |
2nd specimen post dose lactose |
| LP35301-8 |
3rd specimen post dose lactose |
| LP35311-7 |
W Tl-201 IV |
| LP35313-3 |
W Tc-99m DTPA IV |
| LP35315-8 |
W Tc-99m Tetrofosmin IV |
| LP35316-6 |
W dipyridamole IV+W radionuclide IV |
| LP35317-4 |
W adenosine+W Tl-201 IV |
| LP35322-4 |
W Tc-99m Sestamibi IV |
| LP35331-5 |
W stress+W radionuclide IV |
| LP35352-1 |
W adenosine+W radionuclide IV |
| LP35355-4 |
W dipyridamole IV+W Tc-99m Sestamibi IV |
| LP35360-4 |
W stress+W Tl-201 IV |
| LP35365-3 |
at rest+W stress+W Tl-201 IV |
| LP35369-5 |
W stress+W Tc-99m Sestamibi IV |
| LP35373-7 |
W Tc-99m Mertiatide IV |
| LP35400-8 |
W radionuclide gaseous IH |
| LP35404-0 |
W radionuclide IH |
| LP35458-6 |
W particulate radionuclide IV |
| LP35471-9 |
1.5H pre XXX challenge |
| LP35472-7 |
1H pre XXX challenge |
| LP35473-5 |
45M pre XXX challenge |
| LP35474-3 |
5.25H post XXX challenge |
| LP35475-0 |
16H post XXX challenge |
| LP35476-8 |
18H post XXX challenge |
| LP35477-6 |
7D post XXX challenge |
| LP35478-4 |
2.25H pre XXX challenge |
| LP35480-0 |
5M pre XXX challenge |
| LP35481-8 |
100M post XXX challenge |
| LP35482-6 |
110M post XXX challenge |
| LP35483-4 |
8.5H post XXX challenge |
| LP35484-2 |
9.5H post XXX challenge |
| LP35485-9 |
11.5H post XXX challenge |
| LP35486-7 |
12.5H post XXX challenge |
| LP35487-5 |
13H post XXX challenge |
| LP35488-3 |
13.5H post XXX challenge |
| LP35489-1 |
14H post XXX challenge |
| LP35490-9 |
15.5H post XXX challenge |
| LP35491-7 |
17.5H post XXX challenge |
| LP35492-5 |
18.5H post XXX challenge |
| LP35493-3 |
19.5H post XXX challenge |
| LP35494-1 |
20H post XXX challenge |
| LP35495-8 |
20.5H post XXX challenge |
| LP35496-6 |
21.5H post XXX challenge |
| LP35497-4 |
22H post XXX challenge |
| LP35498-2 |
23.5H post XXX challenge |
| LP35499-0 |
3M post XXX challenge |
| LP35500-5 |
6M post XXX challenge |
| LP35501-3 |
9M post XXX challenge |
| LP35502-1 |
12M post XXX challenge |
| LP35503-9 |
14M post XXX challenge |
| LP35504-7 |
16M post XXX challenge |
| LP35505-4 |
27M post XXX challenge |
| LP35506-2 |
25H post XXX challenge |
| LP35507-0 |
26H post XXX challenge |
| LP35508-8 |
27H post XXX challenge |
| LP35509-6 |
28H post XXX challenge |
| LP35510-4 |
29H post XXX challenge |
| LP35511-2 |
30H post XXX challenge |
| LP35512-0 |
31H post XXX challenge |
| LP35513-8 |
36H post XXX challenge |
| LP35514-6 |
3D post XXX challenge |
| LP35515-3 |
2H pre XXX challenge |
| LP35516-1 |
10.75H post XXX challenge |
| LP35517-9 |
20M pre XXX challenge |
| LP35518-7 |
13M pre XXX challenge |
| LP35519-5 |
8M pre XXX challenge |
| LP35520-3 |
3M pre XXX challenge |
| LP35522-9 |
pre-meal |
| LP35523-7 |
10.5H post XXX challenge |
| LP35524-5 |
75M post dose glucose |
| LP35525-2 |
105M post dose glucose |
| LP35526-0 |
pre dose cloNIDine |
| LP35527-8 |
1H post dose cloNIDine |
| LP35528-6 |
1.5H post dose cloNIDine |
| LP35529-4 |
2H post dose cloNIDine |
| LP35530-2 |
pre dose arginine |
| LP35531-0 |
1H post dose arginine |
| LP35532-8 |
1.5H post dose arginine |
| LP35533-6 |
2H post dose arginine |
| LP35534-4 |
3H post dose arginine |
| LP35535-1 |
3.5H post dose arginine |
| LP35536-9 |
4H post dose arginine |
| LP35537-7 |
pre dose triple bolus |
| LP35538-5 |
15M post dose triple bolus |
| LP35539-3 |
30M post dose triple bolus |
| LP35540-1 |
45M post dose triple bolus |
| LP35541-9 |
1H post dose triple bolus |
| LP35542-7 |
1.5H post dose triple bolus |
| LP35543-5 |
2H post dose triple bolus |
| LP35544-3 |
3H post dose triple bolus |
| LP35545-0 |
20M post dose triple bolus |
| LP35585-6 |
immediately after addition of factor VIII depleted plasma |
| LP35605-2 |
50 umol/L |
| LP35606-0 |
100 umol/L |
| LP35608-6 |
resting |
